TABLE 1

Kinetic parameters for the formation of 8-hydroxyefavirenz from efavirenz and 4-hydroxybupropion from bupropion in expressed CYP2B6.1 and CYP2B6.6 without and with coexpression of Cyt b5

Kinetic data are presented as mean ± S.D. (n = 3 incubations were performed in duplicate). In vitro Clint was calculated as Vmax/Km. Kinetic parameters for the formation of 8-hydroxyefavirenz and 4-hydroxybupropion were estimated by fitting the velocity versus substrate concentrations to the simple single-site Michaelis-Menten equation.

Kinetic ParametersWithout Cyt b5With Cyt b5P Value (Comparing with vs. without b5)
CYP2B6.1CYP2B6.6CYP2B6.1CYP2B6.6CYP2B6.1CYP2B6.6
Efavirenz 8-hydroxylation
    Vmax, pmol · min−1 · pmol−11.21 ± 0.151.61 ± 0.11**1.02 ± 0.110.95 ± 0.020.140.00002
    Km, μM3.2 ± 1.08.8 ± 1.6***3.4 ± 0.66.2 ± 2.60.740.14
    Clint, μl · min−1 · pmol0.39 ± 0.080.19 ± 0.04**0.30 ± 0.060.17 ± 0.070.180.69
Bupropion 4-hydroxylation
    Vmax, pmol · min−1 · pmol−113.37 ± 0.9718.55 ± 0.82**15.18 ± 0.9911.77 ± 1.46**0.040.0002
    Km, μM64.2 ± 13.462.6 ± 7.390.6 ± 10.3110.0 ± 29.80.020.02
    Clint, μl · min−1 · pmol−10.21 ± 0.030.30 ± 0.03**0.17 ± 0.020.11 ± 0.04*0.070.0002
  • * P < 0.05,

  • ** P < 0.01, and

  • *** P < 0.001 compared CYP2B6.6 to CYP2B6.1 without and with coexpression of Cyt b5, respectively.

  • Kinetic parameters of CYP2B6.1 with and without Cyt b5 as well as CYP2B6.6 with and without Cyt b5 were also compared.